Clearmind Medicine (CMND) said Wednesday it has received a Nasdaq notice stating it has regained compliance with the exchange's minimum bid price requirement.
The notice stated the closing bid price of the company's common shares was at $1 per share or greater for 10 business days from Dec. 15 through Dec. 29, the company said.
Price: 1.90, Change: +0.04, Percent Change: +2.20
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments